One of the few studies in human medicine to address carnosines effect on CVD, a randomized placebo-controlled clinical trial, found that adding carnosine (500 mg/day for 6 months) to established treatments for chronic heart failure improved cardiopulmonary stress tests, 6-min walk test scores and quality of life [100]
But Payne said that HHS does have the power to prevent a substance from being scheduled
[DOI] [PMC free article] [PubMed] [Google Scholar] 154.Lillig C.H., Berndt C., Vergnolle O., Lnn M.E., Hudemann C., Bill E., Holmgren A
As of 2026, published human RCTs specifically on TB-500 (the synthetic fragment) are not available
B.FleshmanJ
Side Effects: Where the Real Difference Lives This is where the comparison stops being academic and starts being personal